Maravai LifeSciences Holdings Inc (NAS:MRVI)
$ 5.92 0.3 (5.34%) Market Cap: 839.71 Mil Enterprise Value: 780.08 Mil PE Ratio: 0 PB Ratio: 2.43 GF Score: 74/100

Maravai LifeSciences Holdings Inc at Barclays Global Healthcare Conference Transcript

Mar 15, 2023 / 09:00PM GMT
Release Date Price: $15.52 (+0.19%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Good afternoon, everybody. We're wrapping up here. I'm Luke Sergott. I cover life science tools and diagnostics here at Barclays. With me, I have Kevin Herde, CFO; and Deborah Barbara, VP, Strategy and Business Development of Maravai. So I think they're going to kick off here. Are you guys going to kick off with the presentation? Or we can dig into some questions.

Kevin M. Herde
Maravai LifeSciences Holdings, Inc. - Executive VP & CFO

Yes, we will. And thank you for having us during happy hour. Obviously, it led to a large attendance. We'll go [have drinks] afterwards, I promise. Anyway, so again, Kevin Herde, CFO. Happy to walk you all through a few slides just to kind of [tee off] Maravai and kind of refresh people on where we are, who we are, and then we'll get into your questions.

Some forward-looking statements. We do use some non-GAAP measures. So we have some caveats here with regards to that.

Overall, obviously exiting a really -- another really strong

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot